The Future of Oral Drug Delivery: How Altanine’s Enteric Coating Technology Enhances Medication Efficacy and Patient Experience

As the pharmaceutical industry advances, new delivery technologies are transforming how medications are absorbed and utilized by the body. A standout innovation in this field is Altanine’s proprietary enteric coating technology – a solution that offers targeted drug delivery, minimizes side effects, and improves patient compliance.

---

What is Enteric Coating?

Enteric coating is a specialized polymer barrier applied to oral medications to ensure they safely pass through the stomach’s acidic environment before being released in the intestines. Altanine’s enteric coating technology further optimizes this process by maintaining the integrity of the active ingredients, protecting them from stomach acid, and precisely timing their release where they can be best absorbed in the digestive tract. This innovation is particularly beneficial for drugs sensitive to stomach acid or those that may cause irritation if released too soon.

---

Patient Benefits with Altanine’s Enteric Coating Technology

The use of Altanine’s proprietary enteric coating technology provides several distinct advantages for patients:

• Reduced Gastrointestinal Side Effects: By protecting drugs from premature release in the stomach, our coating technology minimizes contact with the stomach lining, reducing side effects often experienced with medications like NSAIDs and acidic compounds.
• Enhanced Absorption and Bioavailability: For drugs like semaglutide and metformin, delayed release in the intestines improves bioavailability, allowing patients to achieve therapeutic effects with lower doses, making treatments more effective.
• Improved Compliance: With minimized side effects and optimized drug release, Altanine’s enteric coating technology contributes to a better patient experience, encouraging adherence to prescribed therapies.

---

Altanine’s Enteric Coating Solutions for Semaglutide and Metformin

Our proprietary enteric coating technology is already making an impact with key medications:

• Semaglutide: Traditionally administered via injection, semaglutide can now be formulated for oral administration using Altanine’s coating technology. This not only preserves the drug’s potency and efficacy but also enhances convenience, offering patients a seamless alternative to injections.
• Metformin: Used widely for diabetes management, metformin benefits significantly from our enteric coating. By delaying its release until it reaches the intestines, our technology reduces gastrointestinal discomfort, providing patients with a smoother, more comfortable experience.

Altanine’s enteric coating technology doesn’t just focus on the pharmacological aspects of these medications; it’s engineered with the patient experience in mind, ensuring therapies that are as effective as they are accessible.

---

The Future of Enteric Coating in Drug Delivery with Altanine

Looking ahead, Altanine’s enteric coating technology holds great promise in the development of new oral therapies. Research continues to expand its application across a range of drugs, particularly those used in managing chronic conditions. As we continue to innovate, our enteric coating technology may pave the way for oral delivery of complex biological compounds, creating new treatment options for patients worldwide.

---

Altanine: Driving Progress in Oral Drug Delivery

At Altanine, our mission is to enhance patient outcomes through cutting-edge drug delivery solutions. Our proprietary enteric coating technology is central to this goal, enabling us to offer therapies that deliver both high efficacy and a better patient experience. As we push the boundaries of what’s possible in oral drug delivery, we invite you to stay connected with us for the latest insights and advancements.

---